Benzyl 4-aminoazepane-1-carboxylate, 95.0%, 100mg

Acide tungstophosphorique hydraté, pa, cristallisé, 50 g, emballage verre

(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid, 95.0%, 10g

N-(Phenylsulfonyl)-N-((trifluoromethyl)thio)benzenesulfonamide, 250mg

(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one, 98%, 25g

N-(5-Bromopentyl)phthalimide, 98.0%, 5g

(6-Isobutoxy-5-methylpyridin-3-yl)boronic acid, 95.0%, 250mg

(R)-2-((tert-butoxycarbonyl)amino)-4-(4-fluorophenyl)butanoic acid, 98%, 500mg

Methyl quinuclidine-4-carboxylate, 95+%, 100mg

Ethyl 2-chloropyrimidine-4-carboxylate, 95.0%, 1g

8-Fluoro-1,4-dioxaspiro[4.5]dec-7-ene, 250mg

2-(Trifluoromethyl)benzal Chloride25g

Pomalidomide-PEG2-azide, 95%, 50mg